CompletedNCT00059267

Prevention of Recurrent Hepatitis B After Liver Transplantation

Studying Acute liver failure

Last synced from ClinicalTrials.gov

Clinical trial records are synced from ClinicalTrials.gov through automated extraction.
Report missing data

Key facts

Sponsor
National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)
Principal Investigator
Anna S Lok, MD
University of Michigan
Intervention
HBIG, Epivir, Hepsera(drug)
Enrollment
317 enrolled
Eligibility
13 years · All sexes
Timeline
20012007

Study locations (1)

Collaborators

University of Michigan

Primary source

Recruitment status, site addresses, contacts, and full eligibility criteria can change between syncs. Always verify with the trial team before planning travel or treatment.

Open NCT00059267 on ClinicalTrials.gov

Other trials for Acute liver failure

Additional recruiting or active studies for the same condition.

See all trials for Acute liver failure

← Back to all trials